3646 results for «449»
3646 results
Leave nothing behind: DCB-only PCI strategy - How DCB evidence has changed today's practice?
22 Sep 2023 – From AICT-AsiaPCR 2023
This session offers an opportunity to stay informed about the recent developments in the International DCB Consensus Group, gain insights into the latest clinical data and real-world experiences related to drug-coated balloon (DCB)-only PCI, understand the safety aspects of DCB in managing complex PCI cases, and...
The importance of SEE-PREP-TREAT in left main bifurcation
22 Sep 2023 – From AICT-AsiaPCR 2023
This session is recommended for you if you are seeking insights into the advantages of using IVUS imaging over visual assessment for better outcomes in left main bifurcation procedures. Discuss with experts the benefits of using RotaCUT in lesion preparation for left main bifurcation and explore...
Essentials of lifetime management in patient undergoing TAVI using novel balloon expandable Myval Octacor THV
22 Sep 2023 – From AICT-AsiaPCR 2023
This session with a LIVE case provides information about the Octacor transcatheter heart valve technology, highlighting its procedural and clinical benefits. It also covers the Octalign technique, which ensures precise alignment of commissural and coronary access, and discusses the precise sizing, positioning, and deployment of Octacor THV.
STEMI complexities
21 Sep 2023 – From AICT-AsiaPCR 2023
Dive into the world of STEMI complexities in this session, from unique cases like anterior STEMI with cardiogenic shock to unconventional approaches for triple vessel disease, and gain insights into topics like calcified left main bifurcation, mechanical causes of myocardial infarction, SCAD mysteries, and more!
References in coronary guidewire loss
16 Jan 2019
Consult the references associated to the clinical research and case reports in coronary guidewire loss complications.
TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation
31 Mar 2026
Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.
Author
